VITASPRING BIOMEDICAL CO. LTD. (VSBC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 01-31. Amounts in USD.

Revenue Annual

0 2M 4M 6M FY19: 17.2K FY19: 17.2K FY20: 15.1K FY20: 15.1K FY21: 248.2K FY22: 5.6M FY23: 0 FY24: 0 FY25: 0 FY26: 0 FY19 FY19 FY20 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Gross Profit Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY19: 13.7K FY19: 13.7K FY20: 1.7K FY20: 1.7K FY21: 112.2K FY22: 2.1M FY23: -3.3M FY24: 0 FY25: 0 FY26: 0 FY19 FY19 FY20 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating Income Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY18: -6.4K FY19: -22.4K FY20: 6.9K FY21: 425.4K FY22: 1.1M FY23: -4.2M FY24: -1.1M FY25: -679.9K FY26: -385.4K FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Net Income Annual

-4.5M -3M -1.5M 0 1.5M 3M 4.5M FY18: -6.4K FY18: -6.4K FY19: -22.4K FY20: 6.9K FY21: 425.4K FY22: 909.6K FY23: -4.2M FY24: -1.1M FY25: -774.9K FY26: -415.4K FY18 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Cost of Revenue Annual

0 1.5M 3M 4.5M FY19: 3.5K FY20: 13.4K FY20: 13.4K FY21: 136K FY22: 3.5M FY23: 3.3M FY24: 0 FY25: 0 FY26: 0 FY19 FY20 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Operating Cash Flow Annual

-300K -200K -100K 0 100K 200K 300K FY19: -34.2K FY20: -105 FY20: 105 FY21: -42.1K FY21: -42.1K FY22: -269.6K FY23: -77.6K FY24: -34.9K FY25: -14.7K FY26: -2.7K FY19 FY20 FY20 FY21 FY21 FY22 FY23 FY24 FY25 FY26

Free Cash Flow Annual

-450K -300K -150K 0 150K 300K 450K FY22: -342.6K FY23: -77.6K FY22 FY23

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 80M 160M 240M FY19: 9.8M FY19: 9.8M FY20: 10.9M FY20: 10.9M FY21: 91.1M FY22: 206M FY23: 206.5M FY24: 207M FY25: 207M FY26: 207M FY19 FY19 FY20 FY20 FY21 FY22 FY23 FY24 FY25 FY26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.02 -0.01 -0.01 0.00 0.01 0.01 0.02 Q1 '19: 0.00 Q4 '19: 0.00 Q1 '20: 0.00 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: 0.00 Q4 '21: 0.00 Q4 '23: -0.02 Q1 '24: -0.02 Q2 '24: -0.02 Q3 '24: -0.02 Q4 '24: -0.01 Q1 '25: -0.01 Q2 '25: -0.01 Q3 '25: -0.01 Q4 '25: 0.00 Q1 '26: 0.00 Q2 '26: 0.00 Q3 '26: 0.00 Q4 '26: 0.00 Q1 '27: 0.00 Q1 '19 Q4 '20 Q3 '21 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.